Optimizing IBD treatment by studying gut viruses
Part of Digestive system clinical trials.
This study looks at how tiny viruses in your gut might affect your IBD. It tests whether understanding these viruses can help improve treatment for people with ulcerative colitis, Crohn's disease, or related forms of IBD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had ulcerative colitis, Crohn's disease, or IBD with PSC for at least 6 months.
- You are 18 years or older.
- Your IBD treatment has been stable for the past 3 months.
- You have not used antibiotics in the last 3 months.
- You are not pregnant or breastfeeding, and you do not have other conditions that affect gut health (like type 1 diabetes, other autoimmune diseases, cancer, or severe obesity).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Crohn's disease or ulcerative colitis (and healthy volunteers) to understand what affects the disease's progression and complications. It looks at factors like your gut bacteria and immune treatments.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study uses information from your gut bacteria (microbiome) to create personalized nutrition advice. It is for people with gut conditions like IBD, IBS, or celiac disease, as well as healthy volunteers.
This study looks at bacteria in your gut that may produce chemicals linked to ongoing pain in Crohn's disease or ulcerative colitis, even when the disease itself is not very active. Researchers want to understand why some people still have moderate to severe abdominal pain even after their inflammation has calmed down.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.